<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Pharmacology/kinetics News</title> 
<link>http://www.mdlinx.com/GILinx/news.cfm/newspage/1/spec_id/13/subspec_id/481</link> 
<description>Pharmacology/kinetics</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[New modalities and paradigms for sedation: new sedation agents]]></title> 
<link>http://www.mdlinx.com/GILinx/xml-article.cfm/2985136</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Techniques in Gastrointestinal Endoscopy </b>]]></description> 
<guid>http://www.mdlinx.com/GILinx/xml-article.cfm/2985136</guid>
</item> 
 

<item> 
<title><![CDATA[No beneficial effects of amantadine in treatment of chronic hepatitis C patients]]></title> 
<link>http://www.mdlinx.com/GILinx/xml-article.cfm/2989940</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Digestive and Liver Diseases</b>]]></description> 
<guid>http://www.mdlinx.com/GILinx/xml-article.cfm/2989940</guid>
</item> 
 

<item> 
<title><![CDATA[Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer]]></title> 
<link>http://www.mdlinx.com/GILinx/xml-article.cfm/2988441</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Irish Journal of Medical Science</b>]]></description> 
<guid>http://www.mdlinx.com/GILinx/xml-article.cfm/2988441</guid>
</item> 


 

<item> 
<title><![CDATA[Target-controlled infusions/patient-controlled sedation]]></title> 
<link>http://www.mdlinx.com/GILinx/xml-article.cfm/2985138</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Techniques in Gastrointestinal Endoscopy </b>]]></description> 
<guid>http://www.mdlinx.com/GILinx/xml-article.cfm/2985138</guid>
</item> 
 

<item> 
<title><![CDATA[Delayed Colonic Perforation after ESD in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature]]></title> 
<link>http://www.mdlinx.com/GILinx/xml-article.cfm/2986643</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>The Internet Journal of Gastroenterology</b>]]></description> 
<guid>http://www.mdlinx.com/GILinx/xml-article.cfm/2986643</guid>
</item> 
 

<item> 
<title><![CDATA[A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer]]></title> 
<link>http://www.mdlinx.com/GILinx/xml-article.cfm/2984076</link> 
<pubDate>12/18/2009</pubDate> 
<description><![CDATA[<b>Investigational New Drugs</b>]]></description> 
<guid>http://www.mdlinx.com/GILinx/xml-article.cfm/2984076</guid>
</item> 
 
 


  


</channel> 
</rss>

